A Multi-Center, Open-Label, Prospective Study of Cannula Injection of Small-Particle Hyaluronic Acid Plus Lidocaine (SPHAL) for Lip Augmentation.

CONCLUSION: SPHAL was well tolerated and effective following injection with a blunt-tipped microcannula. No unanticipated safety concerns were identified in the study population.</p> <p><em>J Drugs Dermatol. 2018;17(1):10-16.</em></p>.
PMID: 29320583 [PubMed - in process]

Source: Journal of Drugs in Dermatology - January 12, 2018 Category: Dermatology Tags: J Drugs Dermatol Source Type: research